Korean J Fam Pract 2019; 9(2): 185-189  https://doi.org/10.21215/kjfp.2019.9.2.185
Seroprevalence of Surface Antigen and Antibody Positive Rate of Hepatitis B Virus in Low-Income People
Hyewon Kim1, Mijung Sim2,*, Suyoung Jahng1, Jinyi Jeong1, Sunghwa Lee1, Hyorim Son1
1Department of Family Medicine, Gwangju Veterans Hospital; 2Deptartement of Nursing, Gwangju Health University, Gwangju, Korea
Mijung Sim, Tel: +82-62-958-7684, Fax: +82-62-958-7689, E-mail: smj7684@hanmail.net, ORCID: http://orcid.org/0000-0001-9674-9574
Received: July 24, 2018; Revised: October 17, 2018; Accepted: November 13, 2018; Published online: April 20, 2019.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: The purpose of this study was to provide health screening for low-income people and early diagnosis and treatment for health risk factors and diseases for the promotion of the health of vulnerable people. This study was also aimed toward the implementation of a comprehensive cancer health screening system to improve quality of life.
Methods: This study was conducted in 1,546 subjects aged >40 years who underwent free cancer screening between February and December 2017 in the Jeollanam-do region. In the first, we performed a survey HBsAg, Anti-HBs, 54 peoples with hepatitis B abnormalities were checked to secondary screening, HBeAg/Anti-HBe, HBV DNA.
Results: The overall HBsAb total seropositivity rate was 59.8% (924/1,546), and the HBsAb total seronegativity rate was 40.2% (622/1,546). The HBsAg total seropositivity rate was 3.8% (58/1,546) overall, 1.7% (26/1,546) in the men, and 2.1% (32/1,546) in the women. The HBeAg seropositivity rate was 11.1% (6/54) in the second hepatitis B screening.
Conclusion: We found that the positivity and negativity rates of HBsAb (Anti-HBs) were similar to those reported in other studies, but the positivity rate of HBeAg was slightly higher in the second hepatitis screening. In future surveys, factors must be analyzed, including an additional investigation of the related health risk factors to confirm the factors that affect diagnosis and initial evaluation results.
Keywords: Hepatitis B; Seroprevalence; Vaccination
References
  1. Moradpour D, Wands JR. Understanding hepatitis B virus infection. N Engl J Med 1995; 332: 1092-3.
    Pubmed CrossRef
  2. Kim YS, Park KS, Lee SI, Moon YM, Kang JK, Park IS, et al. Clinical distribution profiles of hepatitis B virus markers in patients with liver disease. Korean J Gastroenterol 1983; 15: 7-15.
  3. Shin HS, Han KH, Park SJ, Ahn SK, Chon CY, Moon YM, et al. The prevalence of hepatitis virus infection and clinical characteristics in patients with hepatocellular carcinoma. Korean J Med 1994; 46: 467-77.
  4. Ahn YO. A review study on descriptive epidemiology of HBs-Antigen in Korea. Korean J Epidemiol 1982; 4: 35-45.
  5. Yoo SW, Lee KK, Park HS. A study on HBsAg and anti-HBs positivities in health screening. Korean J Clin Lab Sci 2000; 32: 187-93.
  6. Hong KS, Han IS, Kim JG. Changes in hepatitis B surface antigen and antibody positive rate in Korean patients in the last 10 years. J Clinical Pathol Qual Control 1993; 15: 367-76.
  7. Chi HW, Kim SJ. The follow up study of HbsAg and Anti-HBs positivities in the bank workers. Korean J Gastroenterol 1988; 20: 330-8.
  8. Jung BC, Lee SH, Kim DS, Kim SI. Prevalence of HbsAg and anti-HCV among Korean blood donors. Korean J Blood Transfus 1994; 5: 143-50.
  9. Kim YA. Trend in seroprevalence of hepatitis B surface antigen (HBs Ag) in Korea, 2001-2011 [Internet]. Osong: Korea Centers for Disease Control and Prevention [cited 2018 Jul 5].
    Available from: http://www.cdc.go.kr/CDC/cms/content/mobile/63/21863_view.html
  10. Hong SG, Kim JH, Lee YS, Yoon E, Lee HJ, Hwang JK, et al. [The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study]. Korean J Hepatol 2010; 16: 49-56. Korean.
    Pubmed CrossRef
  11. Yim HJ, Chang YJ, Byun KS, Suh YS, Kim JH, Kim JY, et al. The changing patterns of acute hepatitis B infection in Korea in the early 2000's. Korean J Med 2005; 69: 601-7.
  12. Han JY, Jung TW, Koh DK, Kim JH. A survey for changed control policies of hepatitis B in Republic of Korea. Korean J Pediatr Infect Dis 2011; 18: 12434.
    CrossRef
  13. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-66.
    Pubmed KoreaMed CrossRef
  14. Kim DS, Kim YS, Kim JY, Ahn YO. A study on the seropositivity of HBsAg among biennial health examinees: a nation-wide multicenter survey. Korean J Prev Med 2002; 35: 129-35.
  15. Koh HM, Son JS. Seroprevalence of hepatitis A and B virus antibody of employees among three companies with different health policy. J Korean Soc Occup Environ Hyg 2015; 25: 229-35.
    CrossRef
  16. Kaneko S, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH. Detection of hepatitis B virus DNA in serum by polymerase chain reaction: Application for clinical diagnosis. 1990; 99: 799-804.
    CrossRef
  17. Korea Centers for Disease Control and Prevention. 2014-2015 infectious disease surveillance yearbook. Osong: Korea Centers for Disease Control and Prevention; 2016. p. 531-2.
  18. Oh TG, Yi HR, Byun JK, Sung E, Kim HW, Lee SH. Serorevalence of hepatitis B virus markers amoung adult. Korean J Fam Pract 2015; 5(Suppl 3): S377-81.
  19. Korea Centers for Disease Control and Prevention. The fourth Korea national health and nutrition examination survey (KNHANES III). Health examination. Osong: Korea Centers for Disease Control and Prevention; 2008. p. 70-1.
  20. Oh MK, Kim JS, Lee YB, Han JH. Seroprevalence of hepatitis B virus markers among adult in a Youngdong area of Kwangwon Province. J Korean Acad Fam Med 2000; 21: 91-9.
  21. Kim YH, Shin YS. A study on the positive rate of HBsAg and anti-HBs in the physical checkup persons. Korean J Clin Lab Sci 2003; 35: 99-104.
  22. Lee GY, Gang MK, Kim Y, Lee GH, Kim YB, Kim HY, et al. Nationwide seroprevalence of HBsAg and anti-HCV among general population in Korea. Clin Mole Hepatol 2001; 7: 77.
  23. Korea Centers for Disease Control and Prevention. Korea National Health and Nutrition Survey, 1999. Osong: Korea Centers for Disease Control and Prevention.
  24. Korea Centers for Disease Control and Prevention. Korea National Health and Nutrition Survey, 2016. Osong: Korea Centers for Disease Control and Prevention.
  25. Korean Association for the Study of the Liver. Chronic hepatitis B clinical practice guideline. Seoul: Korean Association for the Study of the Liver; 2018. p. 22-7.

This Article


Author ORCID Information

Services
Social Network Service

e-submission

Archives